Reduced physiological complexity in robust elderly adults with the APOE ε4 allele

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Cheng, Daniel ^a   Tsai, Shih Jen ^b,c   Hong, Chen Jee ^b,c   Yang, Albert C ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Chutung Veterans Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; ENTROPY; FEMALE; GENE FREQUENCY; GENOTYPE; HEART HEMODYNAMICS; HEART RATE VARIABILITY; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; NONLINEAR SYSTEM; NORMAL HUMAN; PATIENT PARTICIPATION; SEX DIFFERENCE; TIME SERIES ANALYSIS; AGING; ALLELE; GENETICS; GERIATRIC ASSESSMENT; HEART RATE; METHODOLOGY; PHYSIOLOGY;

AGED; AGED, 80 AND OVER; AGING; ALLELES; APOLIPOPROTEIN E4; FEMALE; GENOTYPE; GERIATRIC ASSESSMENT; HEART RATE; HUMANS; MALE; PHYSIOLOGY;

EID: 70450192899     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007733     Document Type: Article

References (47)

1. Park SK, O'Neill MS, Wright RO, Hu H, Vokonas PS, et al. (2006) HFE genotype, particulate air pollution, and heart rate variability: a gene-environment interaction. Circulation 114: 2798-2805.
2. Goldberger AL, Amaral LA, Hausdorff JM, Ivanov P, Peng CK, et al. (2002) Fractal dynamics in physiology: alterations with disease and aging. Proc Natl Acad Sci U S A 99 Suppl 1: 2466-2472.
3. Goldberger AL, Peng CK, Lipsitz LA (2002) What is physiologic complexity and how does it change with aging and disease? Neurobiol Aging 23: 23-26.
4. Vaillancourt DE, Newell KM (2002) Changing complexity in human behavior and physiology through aging and disease. Neurobiol Aging 23: 1-11.
5. Kirkwood TB (2002) Changing complexity in aging: a metric not an hypothesis. Neurobiol Aging 23: 21-22.
6. Utermann G, Hardewig A, Zimmer F (1984) Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 65: 237-241.
7. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, et al. (1994) Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 272: 1666-1671.
8. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, et al. (1995) Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91: 265-269.
9. Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, et al. (2009) APOE-related mortality: Effect of dementia, cardiovascular disease and gender. Neurobiol Aging 30: 1545-1551.
10. Christensen H, Batterham PJ, Mackinnon AJ, Jorm AF, Mack HA, et al. (2008) The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample. BMC Geriatr 8: 14.
11. Reed T, Carmelli D, Swan GE, Breitner JC, Welsh KA, et al. (1994) Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch Neurol 51: 1189-1192.
12. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
13. Peng CK, Buldyrev SV, Hausdorff JM, Havlin S, Mietus JE, et al. (1994) Non-equilibrium dynamics as an indispensable characteristic of a healthy biological system. Integr Physiol Behav Sci 29: 283-293.
14. Jak AJ, Houston WS, Nagel BJ, Corey-Bloom J, Bondi MW (2007) Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dement Geriatr Cogn Disord 23: 382-389.
15. Isoniemi H, Kurki T, Tenovuo O, Kairisto V, Portin R (2006) Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury. Neurology 67: 756-760.
16. Enzinger C, Ropele S, Smith S, Strasser-Fuchs S, Poltrum B, et al. (2004) Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4. Ann Neurol 55: 563-569.
17. Geroldi C, Pihlajamaki M, Laakso MP, DeCarli C, Beltramello A, et al. (1999) APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 53: 1825-1832.
18. Ho KK, Moody GB, Peng CK, Mietus JE, Larson MG, et al. (1997) Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics. Circulation 96: 842-848.
19. Chiu KM, Chan HL, Chu SH, Lin TY (2007) Carvedilol can restore the multifractal properties of heart beat dynamics in patients with advanced congestive heart failure. Auton Neurosci 132: 76-80.
20. Makikallio TH, Koistinen J, Jordaens L, Tulppo MP, Wood N, et al. (1999) Heart rate dynamics before spontaneous onset of ventricular fibrillation in patients with healed myocardial infarcts. Am J Cardiol 83: 880-884.
21. Tapanainen JM, Thomsen PE, Kober L, Torp-Pedersen C, Makikallio TH, et al. (2002) Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol 90: 347-352.
22. Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, et al. (1994) Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 90: 878-883.
23. Yeh GY, Wood MJ, Lorell BH, Stevenson LW, Eisenberg DM, et al. (2004) Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. Am J Med 117: 541-548.
24. Yeh GY, Mietus JE, Peng CK, Phillips RS, Davis RB, et al. (2008) Enhancement of sleep stability with Tai Chi exercise in chronic heart failure: preliminary findings using an ECG-based spectrogram method. Sleep Med 9: 527-536.
25. Ghebremedhin E, Schultz C, Thal DR, Rub U, Ohm TG, et al. (2001) Gender and age modify the association between APOE and AD-related neuropathology. Neurology 56: 1696-1701.
26. Mortensen EL, Hogh P (2001) A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 57: 89-95.
27. Wenham PR, Price WH, Blandell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337: 1158-1159.
28. Tsai SJ, Gau YT, Liu ME, Hsieh CH, Liou YJ, et al. (2008) Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia. Neurosci Lett 433: 158-162.
29. Yang AC, Tsai SJ, Hong CJ, Yang CH, Hsieh CH, et al. (2008) Association between heart rate variability and cognitive function in elderly community-dwelling men without dementia: a preliminary report. J Am Geriatr Soc 56: 958-960.
30. Liu HC, Hong CJ, Wang SJ, Fuh JL, Wang PN, et al. (1999) ApoE genotype in relation to AD and cholesterol: a study of 2,326 Chinese adults. Neurology 53: 962-966.
31. Hong CJ, Liu TY, Liu HC, Wang SJ, Fuh JL, et al. (1996) Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population. Neurology 46: 1749-1751.
32. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, et al. (1991) The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49: 338-349.
33. Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, et al. (1996) Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology 46: 673-677.
34. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, et al. (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55: 964-968.
35. Kuusisto J, Koivisto K, Kervinen K, Mykkanen L, Helkala EL, et al. (1994) Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. Br Med J 309: 636-638.
36. Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, et al. (2000) PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation 101: E215-220.
37. Mietus JE, Peng CK, Henry I, Goldsmith RL, Goldberger AL (2002) The pNNx files: re-examining a widely used heart rate variability measure. Heart 88: 378-380.
38. Task-Force (1996) Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043-1065.
39. Goldberger JJ, Challapalli S, Tung R, Parker MA, Kadish AH (2001) Relationship of heart rate variability to parasympathetic effect. Circulation 103: 1977-1983.
40. Katona PG, Jih F (1975) Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. J Appl Physiol 39: 801-805.
41. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, et al. (1985) Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 248: H151-153.
42. Malliani A, Lombardi F, Pagani M (1994) Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J 71: 1-2.
43. Bar-Yam Y (1997) Dynamics of complex systems: Westview Press..
44. Costa M, Goldberger AL, Peng CK (2002) Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett 89: 068102.
45. Huang NE, Shen Z, Long SR, Wu MLC, Shih HH, et al. (1998) The empirical mode decomposition and the Hilbert spectrum for nonlinear and non-stationary time series analysis. Proc R Soc London, Ser A 454: 903-995.
46. Wu Z, Huang NE, Long SR, Peng CK (2007) On the trend, detrending, and variability of nonlinear and nonstationary time series. Proc Natl Acad Sci U S A 104: 14889-14894.
47. Costa M, Goldberger AL, Peng CK (2005) Multiscale entropy analysis of biological signals. Phys Rev E 71: 021906.